JPRN-UMIN000001131已完成2 期
Gemcitabine-carboplatin for elderly patients with advanced non-small cell lung cancer : a phase II study of the Niigata Lung Cancer Treatment Group - Gemcitabine-carboplatin for elderly patients with advanced non-small cell lung cancer : a phase II study of the Niigata Lung Cancer Treatment Group
iigata Lung Cancer Treatment Group0 个研究点目标入组 35 人开始时间: 2008年5月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients were excluded if they had any active concomitant malignancies, symptomatic brain metastases, past history of severe allergic reactions to drugs, interstitial pneumonia identified by chest X-ray, superior vena cava syndrome, or other serious complications, such as uncontrolled angina pectoris, myocardial infarction within 3 months, heart failure, uncontrolled diabetes mellitus or hypertension, uncontrolled massive pleural effusion or ascites.
研究者
相似试验
进行中（未招募）
不适用
Carboplatin Gemcitabine as second line treatment in platinum sensitive advanced ovarian cancer phase II study on a new schedule. - NDMedDRA version: 8.1Level: PTClassification code 10061328Term: Ovarian epithelial cancerOvarian cancerEUCTR2006-002116-10-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI32
未知
2 期
Phase II Study of Gemcitabine + S-1 in Elderly Patients With Non-Small Cell Lung Cancernon-small cell lung cancerJPRN-UMIN000001032ational Hospital Organization Lung Cancer Study Group35
招募中
1 期
Gemcitabine and carboplatin induction chemotherapy followed by concurrent cisplatin and IMRT for locally advanced nasopharyngeal cancerACTRN12605000509662Peter MacCallum Cancer Centre30
已完成
2 期
Gemcitabine versus gemcitabine-carboplatin for elderly patients with advanced non-small cell lung cancer : a prospective randomized phase II study of the Niigata Lung Cancer Treatment Groupon-small cell lung cancerJPRN-UMIN000001129iigata Lung Cancer Treatment Group60
已完成
不适用
A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urotheliumCancerISRCTN88259320School of Medicine, Zhejiang University (China)39